Ankle-brachial index and cardiovascular risk prediction: An analysis of 11,594 individuals with 10-year follow-up

Atherosclerosis

Volumn 220, Issue 1, 2012, Pages 160-167

  Murphy, Timothy P ^a,b   Dhangana, Rajoo ^a,c   Pencina, Michael J ^d,e   D'Agostino, Ralph B ^d,e  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c BRIDGEPORT HOSPITAL   (United States)

^d BOSTON UNIVERSITY   (United States)

^e Boston University   (United States)

Author keywords

Ankle brachial index; Cardiac biomarkers; Cardiovascular disease; Cardiovascular disease risk factors; Coronary heart disease; Framingham Risk Score

Indexed keywords

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AFRICAN AMERICANS; ANKLE BRACHIAL INDEX; CARDIOVASCULAR DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84155169041     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.037     Document Type: Article

References (40)

1. Anonymous Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
2. Kannel W.B., Doyle J.T., McNamara P.M., Quickenton P., Gordon T. Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation 1975, 51:606-613.
3. Ridker P.M., Brown N.J., Vaughan D.E., Harrison D.G., Mehta J.L. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004, 109:IV6-IV19.
4. Khot U.N., Khot M.B., Bajzer C.T., et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003, 290:898-904.
5. Murphy T.P., Dhangana R., Pencina M.J., Zafar A.M., D'Agostino R.B. Performance of current guidelines for coronary heart disease prevention: optimal use of the Framingham-based risk assessment. Atherosclerosis 2011, 216:452-457.
6. Brindle P., Emberson J., Lampe F., et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003, 327:1267.
7. Orford J.L., Sesso H.D., Stedman M., et al. A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. Am Heart J 2002, 144:95-100.
8. Reynolds T.M., Twomey P.J., Wierzbicki A.S. Concordance evaluation of coronary risk scores: implications for cardiovascular risk screening. Curr Med Res Opin 2004, 20:811-818.
9. Greenland P., Smith S.C., Grundy S.M. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001, 104:1863-1867.
10. Dhangana R., Murphy T.P., Pencina M.J., Zafar A.M. Prevalence of low ankle-brachial index elevated plasma fibrinogen and CRP across Framingham risk categories: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Atherosclerosis 2011, 216:174-179.
11. Ankle Brachial Index Collaboration, Fowkes F.G., Murray G.D., et al. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008, 300:197-208.
12. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006, 113:e463-e654.
13. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007, 33(Suppl. 1):S1-S75.
14. Graham I., Atar D., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice: full text Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl. 2):S1-S113.
15. Beckman J.A., Jaff M.R., Creager M.A. The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit?. Circulation 2006, 114:861-866.
16. Anon. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989, 129:687-702.
17. Rose G., McCartney P., Reid D.D. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977, 31:42-48.
18. D'Agostino R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
19. Ridker P.M., Paynter N.P., Rifai N., Gaziano J.M., Cook N.R. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 2008, 118:2243-2251. 4 pp. following 2251.
20. Ridker P.M., Buring J.E., Rifai N., Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007, 297:611-619.
21. Shin J.Y., Lee H.R., Lee D.C. Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes. Cardiovasc Diabetol 2011, 10:30.
22. Weatherley B.D., Nelson J.J., Heiss G., et al. The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) Study, 1987-2001. BMC Cardiovasc Disord 2007, 7:3.
23. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992, 326:381-386.
24. Antolini L., Boracchi P., Biganzoli E. A time-dependent discrimination index for survival data. Stat Med 2005, 24:3927-3944.
25. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172. discussion pp. 207-12.
26. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110:227-239.
27. Resnick H.E., Foster G.L. Prevalence of elevated ankle-brachial index in the United States 1999 to 2002. Am J Med 2005, 118(6):676-679.
28. Dhangana R., Murphy T.P., Coll J.R., et al. Prevalence of abnormal ankle-brachial index among individuals with low or intermediate Framingham Risk Scores. J Vasc Interv Radiol 2011, 22(8):1077-1082.
29. Sanna G., Alesso D., Mediati M., et al. Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk: Italian results from the PANDORA study. BMC Cardiovasc Disord 2011, 11(1):59.
30. Fibrinogen Studies Collaboration, Danesh J., Lewington S., et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005, 294:1799-1809.
31. Zethelius B., Berglund L., Sundstrom J., et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008, 358:2107-2116.
32. Wang T.J., Gona P., Larson M.G., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006, 355:2631-2639.
33. Olsen M.H., Hansen T.W., Christensen M.K., et al. N-terminal pro-brain natriuretic peptide but not high sensitivity C-reactive protein improves cardiovascular risk prediction in the general population. Eur Heart J 2007, 28:1374-1381.
34. Cook N.R. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007, 115:928-935.
35. Pepe M.S., Janes H., Longton G., Leisenring W., Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004, 159:882-890.
36. Koji Y., Tomiyama H., Ichihashi H., et al. Comparison of ankle-brachial pressure index and pulse wave velocity as markers of the presence of coronary artery disease in subjects with a high risk of atherosclerotic cardiovascular disease. Am J Cardiol 2004, 94:868-872.
37. Richart T., Kuznetsova T., Wizner B., Struijker-Boudier H.A., Staessen J.A. Validation of automated oscillometric versus manual measurement of the ankle-brachial index. Hypertens Res 2009, 32:884-888.
38. Heald C.L., Fowkes F.G., Murray G.D., Price J.F. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 2006, 189:61-69.
39. Diehm C., Lange S., Darius H., et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006, 27:1743-1749.
40. Lamina C., Meisinger C., Heid I.M., et al. Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13 years of follow-up. Eur Heart J 2006, 27:2580-2587.